Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays

Y Hu, S Li, F Liu, L Geng, X Shu, J Zhang - Bioorganic & Medicinal …, 2015 - Elsevier
Serine/threonine-specific cyclin-dependent kinases (CDKs) are key regulatory elements in
eukaryotic cell cycle progression, and the dysregulation of CDKs has been implicated in …
被引用次数：21 相关文章

Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays

Y Hu, S Li, F Liu, L Geng, X Shu… - … & medicinal chemistry …, 2015 - pubmed.ncbi.nlm.nih.gov
Serine/threonine-specific cyclin-dependent kinases (CDKs) are key regulatory elements in
eukaryotic cell cycle progression, and the dysregulation of CDKs has been implicated in …

Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays

Y Hu, S Li, F Liu, L Geng, X Shu, J Zhang - Bioorganic & Medicinal …, 2015 - infona.pl
Serine/threonine-specific cyclin-dependent kinases (CDKs) are key regulatory elements in
eukaryotic cell cycle progression, and the dysregulation of CDKs has been implicated in …

Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays

Y Hu, S Li, F Liu, L Geng, X Shu… - Bioorganic & Medicinal …, 2015 - hero.epa.gov
Serine/threonine-specific cyclin-dependent kinases (CDKs) are key regulatory elements in
eukaryotic cell cycle progression, and the dysregulation of CDKs has been implicated in …

Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays.

Y Hu, S Li, F Liu, L Geng, X Shu… - Bioorganic & Medicinal …, 2015 - europepmc.org
Serine/threonine-specific cyclin-dependent kinases (CDKs) are key regulatory elements in
eukaryotic cell cycle progression, and the dysregulation of CDKs has been implicated in …